Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RAD51 is a druggable target that sustains replication fork progression upon DNA replication stress. | PLoS One | 2022 | 35969531 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Management of a Girl With Delayed Puberty and Elevated Gonadotropins. | J Endocr Soc | 2022 | 35935072 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cardiomyopathy Disorder Genes Underlie Pediatric Myocarditis-Further Impact of Heterozygous Immune Disorder Gene Variants? | J Cardiovasc Dev Dis | 2022 | 35877578 | PubTator, text mining | PubMed |
| Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets. | Front Oncol | 2022 | 35875106 | PubTator, text mining | PubMed |
| Next-generation sequencing reveals novel variants and large deletion in FANCA gene in Polish family with Fanconi anemia. | Orphanet J Rare Dis | 2022 | 35854323 | PubTator, text mining | PubMed |
| XRCC2 reduced the sensitivity of NSCLC to radio-chemotherapy by arresting the cell cycle. | Am J Transl Res | 2022 | 35836870 | PubTator, text mining | PubMed |
| Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study. | Cancer Res | 2022 | 35834270 | PubTator, text mining | PubMed |
| Gilteritinib Enhances Anti-Tumor Efficacy of CDK4/6 Inhibitor, Abemaciclib in Lung Cancer Cells. | Front Pharmacol | 2022 | 35814226 | PubTator, text mining | PubMed |
| Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes. | Int J Environ Res Public Health | 2022 | 35805770 | PubTator, text mining | PubMed |
| Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer. | Cancers (Basel) | 2022 | 35805063 | PubTator, text mining | PubMed |
| Strand annealing and motor driven activities of SMARCAL1 and ZRANB3 are stimulated by RAD51 and the paralog complex. | Nucleic Acids Res | 2022 | 35801922 | PubTator, text mining | PubMed |
| The Great Majority of Homologous Recombination Repair-Deficient Tumors Are Accounted for by Established Causes. | Front Genet | 2022 | 35783256 | PubTator, text mining | PubMed |
| Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives. | J Adv Res | 2022 | 35777908 | PubTator, text mining | PubMed |
| The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer. | Medicine (Baltimore) | 2022 | 35777046 | PubTator, text mining | PubMed |
| WASp modulates RPA function on single-stranded DNA in response to replication stress and DNA damage. | Nat Commun | 2022 | 35768435 | PubTator, text mining | PubMed |
| Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin. | Asian Pac J Cancer Prev | 2022 | 35763645 | PubTator, text mining | PubMed |
| Medulloblastoma and the DNA Damage Response. | Front Oncol | 2022 | 35747808 | PubTator, text mining | PubMed |
| Deep Sequencing of Early T Stage Colorectal Cancers Reveals Disruption of Homologous Recombination Repair in Microsatellite Stable Tumours with High Mutational Burdens. | Cancers (Basel) | 2022 | 35740599 | PubTator, text mining | PubMed |
| Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients. | Medeni Med J | 2022 | 35734982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=16